新型药物和T细胞淋巴瘤的治疗进展
Yuko Shirouchi1, Dai Maruyama2
1Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-Ku, Tokyo, 135-8550, Japan.
International journal of hematology
|January 27, 2026
概括
周围T细胞淋巴瘤 (PTCL) 是一种具有不良结果的侵袭性癌症. 新型药物和分子分析为治疗复发性或耐火性PTCL提供了新的希望,进步了精准医学.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 周围T细胞淋巴瘤 (PTCL) 是一种具有攻击性的血液性恶性瘤,在历史上预后不佳.
- 像CHOP这样的标准前线疗法在复发或耐火 (R/R) 环境中有效性有限.
- 布伦图西马布维多丁已改善了CD30阳性PTCL的结果,但R/R疾病仍然具有挑战性.
研究的目的:
- 审查目前对PTCL遗传格局和分子亚型的理解.
- 总结PTCL新型治疗剂的近期临床进展,特别是在R/R环境中.
- 讨论在PTCL中基于生物标志物的治疗分层和精密医学的未来前景.
主要方法:
- 关于PTCL遗传分析,临床试验和治疗策略的综合文献综述.
- 分子亚型的分析,包括结节T卵泡辅助体 (TFH) 淋巴瘤,PTCL-GATA3和PTCL-TBX21.
- 评估新型药物,包括表观遗传调节剂,如基因素脱乙酶抑制剂和EZH1/2抑制剂.
主要成果:
- 分子分析已经完善了PTCL分类,揭示了不同的病原遗传和预后亚型.
- 新型药物,特别是表观遗传调节剂,在特定的PTCL亚型 (例如,TFH衍生) 中表现出显著的活性.
- 生物标志物驱动的患者选择正在成为PTCL精准医学的关键策略.
结论:
- 尽管取得了进展,但R/R PTCL的结果仍然很差,需要新的治疗方法.
- 了解PTCL亚型的遗传环境和分子脆弱性对于治疗开发至关重要.
- 将分子见解转化为生物标记指导疗法,有望改善PTCL的持久临床益处.
相关概念视频
01:13Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
02:22Overview of Advanced Functional Groups
29.7K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.7K
00:56Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
01:29Subviral Agents
556
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
556
01:30Therapeutic Communication
7.9K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.9K
01:26Cholinergic Antagonists: Therapeutic Uses
1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K